U.S. Rep. Rodney Davis (R-Ill.) today called for a clean vote on bipartisan bills to lower costs of prescription drugs after Speaker Pelosi brought a partisan bill to floor last night that will not pass the Senate and President Trump has said he will veto. The Washington Post characterized the partisan bill as ‘putting a political pothole in the way of bipartisan drug pricing bills’ and even several Democrats cautioned against combining these bills.
“It’s unfortunate that Democrats would choose partisanship over sending bipartisan bills to lower prescription drug costs to the President’s desk,” said Davis. “Even members of their own conference have called for a clean vote on drug pricing bills. Let’s get a bipartisan win for the American people and help them be able to afford the cost of their prescription drugs. Throwing hundreds of millions of additional dollars at Obamacare for outreach isn’t going to fix the problem because the problem is people can’t afford the plans being offered.”
Pelosi packaged three drug pricing bills that passed unanimously out of the Energy and Commerce Committee with bills to spend hundreds of millions of dollars to promote Obamacare.
Drug Pricing Bills
Davis is a cosponsor of the CREATES Act (H.R. 965), which would implement reforms to prevent anti-competitive conduct that blocks lower-cost generic drugs from entering the market. Click here to find out more about these bipartisan drug pricing bills (H.R. 965, H.R. 1499, and H.R. 938).
- Provides $100 million a year to spend on outreach to sign people up for Obamacare. This would be ten times the amount we currently spend to promote Medicare enrollment. The Obama Administration spent millions in outreach and enrollment still dropped by 42% between 2015-2017.
- Provides $200 million for states to establish Obamacare marketplaces, despite states, like New Jersey, who have said they can set up an exchange without federal dollars. This funding expired in 2014.
- Includes $100 million a year to fund the Navigator program, which received $62.5 million in grants and enrolled 81,426 individuals in 2017 costing $727 per person and accounted for fewer than one percent of total enrollees.
- Additionally, it prevents states from offering innovative plans to lower costs of Obamacare and increase choices.